Jim Simons’s Accelerate Diagnostics AXDX Stock Holding History

Jim Simons’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-64,200	Closed	-$45K	–	3549
2025 Q1	$45K	Sell	64,200 -42,862	-40%	-$48.8K	﹤0.01%	3298
2024 Q4	$128K	Buy	107,062 +65,984	+161%	+$110K	﹤0.01%	3246
2024 Q3	$70.2K	Buy	+41,078	New	+$60.9K	﹤0.01%	3309
2021 Q2	–	Sell	-7,960	Closed	-$662K	–	3446
2021 Q1	$662K	Sell	7,960 -10,588	-57%	-$1.07M	﹤0.01%	2797
2020 Q4	$1.41M	Buy	18,548 +10,868	+142%	+$973K	﹤0.01%	2325
2020 Q3	$819K	Buy	+7,680	New	+$1.07M	﹤0.01%	2607
2017 Q3	–	Sell	-989	Closed	-$270K	–	3197
2017 Q2	$270K	Buy	+989	New	+$268K	﹤0.01%	2927
2016 Q2	–	Sell	-7,089	Closed	-$1.02M	–	3322
2016 Q1	$1.02M	Buy	+7,089	New	+$1M	﹤0.01%	2583

Other funds holding AXDX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Jim Simons's AXDX Position: Q2 2025 in Review

Jim Simons sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 64,200 shares — an estimated $45K sold.

Jim Simons first reported a position in AXDX in Q1 2016 and held it in 8 quarters. The position peaked at $1.41M in Q4 2020. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

Jim Simons reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
Jim Simons sold 64,200 Accelerate Diagnostics shares in Q2 2025, an estimated $45K.
Jim Simons first reported a position in Accelerate Diagnostics in Q1 2016 and held it in 8 quarters.
Jim Simons's Accelerate Diagnostics position peaked at $1.41M in Q4 2020.
3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.